NexDx Raises $2.6 million in Series B Financing and Capital Term Loan

San Diego biotech NexDx, Inc., successfully closed a $2.1 million Series B financing led by founding investor, City Hill Ventures, LLC, and a $500,000 capital term loan from Silicon Valley Bank.San Diego, CA (PRWEB) June 29, 2012 NexDx, Inc., a science driven molecular diagnostics company providing next generation products and services for personalized medicine in rheumatoid arthritis and other ...

Visit link:

NexDx Raises $2.6 million in Series B Financing and Capital Term Loan

Related Posts

Comments are closed.